Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pharmala Biotech Holdings Inc MDXXF


Primary Symbol: C.MDMA

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.


CSE:MDMA - Post by User

Comment by inviolablspiriton Nov 21, 2024 4:19pm
30 Views
Post# 36324688

RE:Pharmala

RE:PharmalaIt's amazing how many investors begin to freak out (i.e. those on CEO) when a stock pulls back.  No stock goes straight up, there's always down days and pullbacks in there too.   So many of those investors have some unrealistic views on how stocks move day to day, week to week and month to month.   The long term technicals are strong and bullish for this stock.  

If an investor is in the stock for the long-term then just hold your shares and accept the down days with the up days.   If you know how to read technicals then you can try trading your shares.  And if you believe the company has accomplished nothing to this point and has nothing for the future, then sell and move on.  

I think we all know the company has the potential for more news releases any day, any week.  In the meantime, you make your own choices, nobody else can, those are your shares.  Nor should anyone worry about what others do with their shares.    I wouldn't be surprised if the stock trades down to 25 cents while we wait for news.  Pull backs are healthy for a stock.  They reset the technicals.  That gives the stock more room to run past the last high and establish a new support level.  However, good news can always swing this stock back up at anytime just as bad news can drop it past support levels at anytime.  This pullback is based on overbought technicals.  How far it retraces depends on those who sell and those that hold and/or buy.    
<< Previous
Bullboard Posts
Next >>